Top compounds associated with response to CEACAM19


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.038 0.2
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.045 0.2
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA CP466722 GDSC1000 pan-cancer AAC -0.037 0.2
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA KIN001-055 GDSC1000 pan-cancer AAC 0.042 0.2
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.044 0.2
mRNA sotrastaurin CTRPv2 pan-cancer AAC -0.053 0.2
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.057 0.2
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.049 0.2
Download CSV